SME Times is powered by   
Search News
Just in:   • NDA show of strength: Nitish Kumar takes oath as Bihar CM for 10th time, PM Modi attends ceremony   • S. Korea to raise anti-dumping tariffs for 2 Chinese PET film companies  • Govt reviews RBI's proposal on opening foreign bank branches, Indian banks’ global expansion  • Sensex, Nifty end near record highs as financials lead rally  • Renewable energy share in India’s power mix likely to cross 35 pc by 2030 
Last updated: 12 Mar, 2015  

msme-THMB-2010.jpg Govt promoting exports by pharma SMEs: Sitharaman

nirmala-sitharaman
   Top Stories
» Sensex, Nifty end near record highs as financials lead rally
» 26 e-commerce platforms declare compliance with self-audit to eliminate dark patterns: Govt
» Gold edges lower on stronger dollar, Fed minutes weigh on rate-cut hopes
» Financial inclusion, digital transformation are India’s big success stories: DFS Secretary
» Goyal to visit Israel for high-level trade talks, proposed FTA review on agenda
SME Times News Bureau | 12 Mar, 2015
The Minister of State (Independent Charge) in the Ministry of Commerce & Industry Nirmala Sitharaman has informed that her government is taking measures to promote exports by small and medium (SME) Pharmaceutical manufacturers.

In an written reply in Rajya Sabha Wednesday the Minister said, "For technology up-gradation to Micro and Small Enterprises in the pharma sector, Ministry of Micro, Small & Medium Enterprises (MSME) is running Credit Linked Capital Subsidy Scheme (CLCSS) under which Micro and Small Enterprises are entitled to take loan up to Rs. 1.00 crore with 15 percent subsidy."

Drugs for sale or for export are manufactured under license granted by State Licensing Authorities appointed by State governments. Central Drugs Standard Control Organization (CDSCO) has not received any such information that majority of small pharmaceutical manufacturers are doing job work/contract work for bigger pharmaceutical units which export the same under their brand name.

She said that some of the measures taken by the Government to promote exports by small and medium Pharmaceutical manufacturers are:

Financial assistance through Pharmexcil, an Export Promotion Council, is provided under Market Development Assistance and Market Access Initiative Schemes to exporters of Pharmaceutical products particularly small and medium size exporters to promote their exports in various countries.

Trade Delegations/Buyer Seller Meets (BSMs) to various countries are organized, where One-to-One meetings with local buyers/importers, FDA/Regulatory officials are arranged for the benefit of exporters.

Participate in International exhibitions and assist small and medium scale companies by way of providing space in those exhibitions at reasonable costs.

Business Meets are organized in India by inviting buyers/importers/FDA officials to India and one-to-one meetings are arranged. These meets help the industry, particularly small and medium exporters.

Pharmexcil organizes its own Expo in India viz. IPHEX every year, which is helping the small and medium exporters.

Pharmexcil has separate Cells/desks for IPR and AYUSH sector to help the small and medium exporters.

Incentives to Pharmaceutical industry are available in various trade promotion schemes like Focus Market Scheme, Focus Product Scheme, Advance Authorization Scheme etc. in the Foreign Trade Policy (FTP) which also helps the Small and Medium exporters for promoting their exports.

India Brand Pharma Campaign launched since March, 2012 promotes quality, affordable & reliability of Indian medicines.
 
Print the Page Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
₹88.70
₹87
UK Pound
₹119.90
₹116
Euro
₹104.25
₹100.65
Japanese Yen ₹59.20 ₹57.30
As on 30 Oct, 2025
  Daily Poll
Who do you think will benefit more from the India - UK FTA in the long run?
 Indian businesses & consumers.
 UK businesses & consumers.
 Both will gain equally.
 The impact will be negligible for both.
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter